Format

Send to

Choose Destination
Head Neck. 2016 Apr;38 Suppl 1:E221-6. doi: 10.1002/hed.23973. Epub 2015 Sep 9.

Hospital readmission and 30-day mortality after surgery for oral cavity cancer: Analysis of 21,681 cases.

Author information

1
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
2
Department of Surgery, Stanford University School of Medicine, Durham, North Carolina.
3
Duke Cancer Institute, Durham, North Carolina.
4
Duke Clinical Research Institute, Durham, North Carolina.
5
Department of Otolaryngology, Head and Neck Surgery, Yale University School of Medicine, New Haven, Connecticut.

Abstract

BACKGROUND:

Oral cavity squamous cell cancer (SCC) is treated primarily with surgery. Rates of 30-day hospital readmission and mortality after surgery for oral cavity SCC are unknown.

METHODS:

We conducted a retrospective analysis of postoperative 30-day unplanned readmission and mortality in patients with oral cavity SCC in the National Cancer Data Base (NCDB).

RESULTS:

Among 21,681 cases, the 30-day unplanned readmission rate was 3.2%, and the 30-day mortality rate was 1.0%. Male sex (odds ratio [OR] = 1.23; p = .02), stage T3 (OR = 1.55; p = .007), or T4 (OR = 1.52; p = .002), and neck dissection (OR = 1.37; p = .04) were independently associated with readmission. Age 76 to 85 years (OR = 4.80; p < .001), age >85 years (OR = 10.24; p < .001), comorbidity index ≥1 (OR = 2.31; p < .001), and stage T3 (OR = 3.02; p < .001) or T4 (OR = 3.24; p < .001) were associated with 30-day mortality.

CONCLUSION:

Interventions aimed at decreasing hospital readmissions should target high-risk patients identified here. Factors associated with 30-day mortality reflect risk factors for overall mortality. © 2015 Wiley Periodicals, Inc. Head Neck 38: E221-E226, 2016.

KEYWORDS:

30-day mortality; National Cancer Data Base (NCDB); head and neck cancer; oral cancer; readmission

PMID:
25537226
DOI:
10.1002/hed.23973
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center